Approval · Notice of Compliance 5822 · 1994
DOBUTREX: Notice of Compliance 5822
Issued July 29, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5822
- Date
- July 29, 1994
- Company
- Eli Lilly Canada IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in manufacturing
- Therapeutic class
- Sympathomimetic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DOBUTREX | Not yet assigned | — |
Medicinal ingredients
- DOBUTAMINE HCL 12.5 MG per ML